Ce Feng Liu
About Ce Feng Liu
Ce Feng Liu is a Senior Director at MeiraGTx, where he has worked since 2019. He has a background in research and education, having held positions at various institutions including Brandeis University, Amicus Therapeutics, Weill Cornell Medicine, and AstraZeneca Pharmaceuticals.
Current Role at MeiraGTx
Ce Feng Liu serves as Senior Director at MeiraGTx, a position he has held since 2019. His role involves overseeing various projects and initiatives within the organization, which is based in New York, New York. His extensive background in research and development contributes to the company's focus on gene therapy and innovative treatments.
Previous Experience at Amicus Therapeutics
Ce Feng Liu worked at Amicus Therapeutics in two capacities. He first served as Senior Research Investigator I for five months in 2018 and later as Senior Research Investigator II for four months in 2019. Both positions were located in Cranbury, New Jersey, where he contributed to the company's research efforts in biopharmaceuticals.
Academic Background at Brandeis University
Ce Feng Liu studied at Brandeis University from 1997 to 2011, completing a 14-year academic tenure. During this time, he engaged in various academic pursuits that laid the foundation for his career in research and development. He also worked at the university as a student from 2006 to 2009 for three years.
Experience at Weill Cornell Medicine
Ce Feng Liu served as an Instructor at Weill Cornell Medicine from 2014 to 2018. His role involved teaching and mentoring students in the Greater New York City Area, contributing to the academic environment and fostering the next generation of researchers.
Tenure at AstraZeneca Pharmaceuticals
Ce Feng Liu worked at AstraZeneca Pharmaceuticals as a Senior Research Associate from 2001 to 2005. During this four-year period, he was involved in various research projects, contributing to the development of pharmaceutical products and advancing his expertise in the field.